NICOLE AMAN: Open Payments
NPI 1699386367 · GREEN BAY, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,487 in 54 payments from 13 companies in 2025. Trend: 2023 $284 · 2024 $1,186 · 2025 $1,487
Food & beverage: $1,487
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $364 |
| E.R. Squibb & Sons, L.L.C. | 7 | $216 |
| Supernus Pharmaceuticals, Inc. | 11 | $212 |
| Alkermes, Inc. | 7 | $156 |
| Otsuka America Pharmaceutical, Inc. | 2 | $144 |
| Neurocrine BioSciences, Inc. | 5 | $103 |
| Teva Pharmaceuticals USA, Inc. | 3 | $78 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| Lundbeck LLC | 3 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $29 |
Products named: VRAYLAR, COBENFY, Qelbree, REXULTI, ARISTADA, INGREZZA, Auvelity, AUSTEDO XR.
Industry payments across WI — which companies pay providers there.
